Provided by Tiger Trade Technology Pte. Ltd.

Kezar Life Sciences Inc.

7.29
0.0000
Volume:- -
Turnover:- -
Market Cap:53.74M
PE:-0.95
High:7.29
Open:7.29
Low:7.29
Close:7.29
52wk High:7.55
52wk Low:3.53
Shares:7.37M
Float Shares:4.69M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.6600
EPS(LYR):-7.6580
ROE:-59.93%
ROA:-29.52%
PB:0.77
PE(LYR):-0.95

Loading ...

Kalamazoo Clarifies Ashburton Disclosure as Peake Exploration Upside Emerges

TIPRANKS
·
May 29

Aurinia completes tender offer for Kezar, wins 80% of shares tendered

Reuters
·
May 19

Kezar Life Sciences’ Risk Disclosures Rely on Cross-References, Potentially Obscuring Full Risk Picture for Investors

TIPRANKS
·
May 12

Aurinia completes Kezar acquisition at $6.96 per share plus CVR

Reuters
·
May 11

Kezar Q1 net loss narrows to $5.8 million; operating loss narrows to $7.4 million

Reuters
·
May 11

Kezar Life Sciences Inc expected to post a loss of 86 cents a share - Earnings Preview

Reuters
·
May 08

Kalamazoo Taps BurnVoir to Drive Financing for Ashburton Gold Project

TIPRANKS
·
Apr 30

Kalamazoo advances Ashburton drilling, raises A$12.1m and names new CEO

TIPRANKS
·
Apr 21

Kalamazoo Resources Boosts Cash Reserves Through Equity Funding Amid Exploration Spend

TIPRANKS
·
Apr 21

Kalamazoo Director Increases Equity Stake with On-Market Share Purchase

TIPRANKS
·
Apr 08

Kezar Life Sciences Announces Major Executive Leadership Changes

TIPRANKS
·
Apr 04

Aurinia Pharma to buy Kezar Life Sciences for $6.955 a share plus CVR

Reuters
·
Apr 04

Kezar Life Sciences CEO Kirk, CFO Belsky, COO Schiller exit under separation agreements

Reuters
·
Apr 04

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Aura Biosciences Inc (AURA) and Kezar Life Sciences (KZR)

TIPRANKS
·
Mar 31

Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies

TIPRANKS
·
Mar 31

BUZZ-U.S. STOCKS ON THE MOVE-Agnico Eagle Mines, ProPetro, Kezar

Reuters
·
Mar 30

Kezar Life Sciences to Be Acquired by Aurinia

TIPRANKS
·
Mar 30

Aurinia to buy Kezar Life Sciences for USD 6.96 per share plus CVR

Reuters
·
Mar 30

Aurinia Pharmaceuticals Inc - CVR Includes Payments From Zetomipzomib, Everest, Enodia, and Net Cash Over $50 Mln

THOMSON REUTERS
·
Mar 30

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM

Reuters
·
Mar 30